Chi H. To
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Tixagevimab-cilgavimab for the prevention of COVID-19: real-world experience in patients with rheumatic diseases receiving rituximab.
Journal: Clinical and experimental rheumatology
Published: October 22, 2024
Disease activity and quality of life in patients with systemic lupus erythematosus: a validation study using the SLE-DAS.
Journal: Clinical and experimental rheumatology
Published: September 26, 2024
Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case-control study.
Journal: Rheumatology (Oxford, England)
Published: August 06, 2023
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry.
Journal: Rheumatology (Oxford, England)
Published: January 16, 2023
Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.
Journal: Rheumatology (Oxford, England)
Published: November 29, 2022
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
Journal: Clinical rheumatology
Published: September 16, 2022
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Associated with Disease Activity and Risk of Incident Cardiovascular Disease in Patients with Systemic Lupus Erythematosus.
Journal: Inflammation
Published: September 04, 2022
Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients.
Journal: Therapeutic advances in musculoskeletal disease
Published: October 26, 2021
Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis.
Journal: Rheumatology (Oxford, England)
Published: October 25, 2021
Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 Years.
Journal: Frontiers in medicine
Published: June 07, 2020
Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
Journal: Annals of the rheumatic diseases
Published: February 18, 2020
Last Updated: 09/26/2026